Pfizer more than doubled the price of its life-saving COVID-19 drug Paxlovid
The price of the life-saving COVID-19 antiviral drug Paxlovid will more than double as the United States emerges from the emergency phase of the pandemic, pharmaceutical maker Pfizer said Wednesday. The list price, before insurance, will be $1,390 for a five-day treatment. , Pfizer said in a statement. This is 2.6 times higher than the …
